{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:36:42Z","timestamp":1790577402787,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/nn.4508","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T12:31:25Z","timestamp":1486989085000},"page":"497-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":240,"title":["Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy"],"prefix":"10.1038","volume":"20","author":[{"given":"David R","family":"Corey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"BFnn4508_CR1","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel, R.S. et al. Lancet 388, 3017\u20133026 (2016).","journal-title":"Lancet"},{"key":"BFnn4508_CR2","unstructured":"US Food & Drug Administration. Spinraza (nusinersen) injection. \n                    http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2016\/209531Orig1s000TOC.cfm\n                    \n                   (2016)."},{"key":"BFnn4508_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","volume":"11","author":"I Faravelli","year":"2015","unstructured":"Faravelli, I., Nizzardo, M., Comi, G.P. & Corti, S. Nat. Rev. Neurol. 11, 351\u2013359 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnn4508_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni, L. & Krainer, A.R. Nat. Genet. 30, 377\u2013384 (2002).","journal-title":"Nat. Genet."},{"key":"BFnn4508_CR5","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1093\/nar\/gkw533","volume":"44","author":"MA Havens","year":"2016","unstructured":"Havens, M.A. & Hastings, M.L. Nucleic Acids Res. 44, 6549\u20136563 (2016).","journal-title":"Nucleic Acids Res."},{"key":"BFnn4508_CR6","doi-asserted-by":"publisher","first-page":"45476","DOI":"10.1074\/jbc.M107632200","volume":"276","author":"SR Lim","year":"2001","unstructured":"Lim, S.R. & Hertel, K.J. J. Biol. Chem. 276, 45476\u201345483 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnn4508_CR7","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","volume":"5","author":"Y Hua","year":"2007","unstructured":"Hua, Y., Vickers, T.A., Baker, B.F., Bennett, C.F. & Krainer, A.R. PLoS Biol. 5, e73 (2007).","journal-title":"PLoS Biol."},{"key":"BFnn4508_CR8","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini, M.A. et al. Sci. Transl. Med. 3, 72ra18 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFnn4508_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga, C.A. et al. Neurology 86, 890\u2013897 (2016).","journal-title":"Neurology"},{"key":"BFnn4508_CR10","unstructured":"US Food and Drug Administration. FDA approves first drug for spinal muscular atrophy. \n                    http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm534611.htm\n                    \n                   (2016)."},{"key":"BFnn4508_CR11","unstructured":"Corey, D.R. Nat. Rev. Drug Discov. (in the press)."},{"key":"BFnn4508_CR12","doi-asserted-by":"publisher","unstructured":"DeVos, S.L. et al. Sci. Transl. Med. \n                    http:\/\/dx.doi.org\/10.1126\/scitranslmed.aag0481\n                    \n                   (2017).","DOI":"10.1126\/scitranslmed.aag0481"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nn.4508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.4508","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nn.4508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nn.4508.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:22:58Z","timestamp":1684441378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nn.4508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFnn4508"],"URL":"https:\/\/doi.org\/10.1038\/nn.4508","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]},"assertion":[{"value":"13 February 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.R.C. receives licensing income from Ionis Pharmaceuticals for an unrelated discovery.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}